NKE
30
2
UA
59
14
V
66
6
BXP
52
2
DE
56
10
BK
72
4
ADSK
68
2
LH
45
3
PSA
56
5
ADP
66
2
APA
24
3
PLD
48
-5
TGNA
56
3
MOS
46
4
TEL
66
6
ORLY
60
7
RRC
59
-4
SBUX
39
3
MAS
56
5
SWKS
49
11
NKE
30
2
UA
59
14
V
66
6
BXP
52
2
DE
56
10
BK
72
4
ADSK
68
2
LH
45
3
PSA
56
5
ADP
66
2
APA
24
3
PLD
48
-5
TGNA
56
3
MOS
46
4
TEL
66
6
ORLY
60
7
RRC
59
-4
SBUX
39
3
MAS
56
5
SWKS
49
11
Financhill
Back

Janux Therapeutics Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34

JANX
Janux Therapeutics

Last Price:
50.47
Seasonality Move:
7.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Janux Therapeutics Stock Forecast

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 233.8% based on the past 3 years of stock performance.
  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Janux Therapeutics Stock Undervalued?
    The current Janux Therapeutics [JANX] share price is $46.50. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Janux Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 233.8% based on the past 3 years of stock performance.

Janux Therapeutics Stock Rating

Sell
34
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics overpriced?

  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Janux Therapeutics Stock Price History

Is JANX stock going to rise?

  • The current trend is relatively stagnant and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com

52-Week Data

52-Week High:
65.60
52-Week Low:
7.79

Prediction Charts

Market Cap:
2.44B
Price in USD:
46.50
Volume:
785.99K
Beta:
3.60

Technical Analysis

SMA50:
49.99
SMA100:
46.13
SMA200:
43.49
52-Wk Change:
434.48%

Stock Predictions

  • Is Janux Therapeutics stock public?
    Yes, Janux Therapeutics is a publicly traded company.
  • What is the Janux Therapeutics stock quote today?
    The Janux Therapeutics stock price is 46.50 USD today.
  • How to buy Janux Therapeutics stock online?
    You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 53.50 55.80 58.06 52.40
Nov-5 55.46 55.28 56.14 54.01
Nov-6 56.54 54.86 57.48 54.40
Nov-7 55.91 54.21 56.50 53.54
Nov-8 54.81 53.92 55.97 53.61
Nov-11 54.16 53.64 54.97 50.51
Nov-12 52.83 52.91 54.95 52.00
Nov-13 52.92 52.03 53.71 51.93
Nov-14 51.39 51.10 52.87 50.55
Nov-15 50.41 48.76 51.09 48.34
Nov-18 48.70 48.12 49.14 47.04
Nov-19 47.75 49.01 49.74 47.50
Nov-20 48.34 48.96 49.34 47.61
Nov-21 49.04 46.50 49.78 45.95

Janux Therapeutics Earnings

Janux Therapeutics Earnings Report: Per Share Janux Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Janux Therapeutics Forecast Revenue Growth

Janux Therapeutics Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.53 per share.

* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.